National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

isoniazid
A synthetic derivative of nicotinic acid with anti-mycobacterial properties. Although its mechanism of action is still unclear, isoniazid appears to block the synthesis of mycolic acids, major components of the mycobacterial cell wall. This agent is only active against actively growing mycobacteria because, as a pro-drug, it requires activation in susceptible mycobacterial species. Isoniazid also interferes with mycobacterial metabolism of vitamin B6. Resistance occurs due to decreased bacterial wall penetration. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:INH
Chemical structure names:
  • isonicotinic acid hydrazide
  • isonicotinyl hydrazine



Previous:Iscar, Iscomatrix, ISIS 2503, ISIS 3521, ISIS 5132
Next:isosulfan blue, isotretinoin, Isovorin, ispinesib, ISS 1018 CpG oligodeoxynucleotide

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov